Review
doi: 10.1038/nrc706.
Multidrug resistance in cancer: role of ATP-dependent transporters
Affiliations
- PMID: 11902585
- DOI: 10.1038/nrc706
Item in Clipboard
Review
Multidrug resistance in cancer: role of ATP-dependent transporters
Nat Rev Cancer.
2002 Jan.
Abstract
Chemotherapeutics are the most effective treatment for metastatic tumours. However, the ability of cancer cells to become simultaneously resistant to different drugs--a trait known as multidrug resistance--remains a significant impediment to successful chemotherapy. Three decades of multidrug-resistance research have identified a myriad of ways in which cancer cells can elude chemotherapy, and it has become apparent that resistance exists against every effective drug, even our newest agents. Therefore, the ability to predict and circumvent drug resistance is likely to improve chemotherapy.
Similar articles
-
[Drug distribution, resistance to cytostatics and disease pathogenesis: many roles of ABC proteins].Lakartidningen. 2004 Jan 22;101(4):282-7. Lakartidningen. 2004. PMID: 14979001 Review. Swedish. No abstract available.
-
Modulation of multidrug resistance efflux pump activity to overcome chemoresistance in cancer.Curr Opin Pharmacol. 2006 Aug;6(4):350-4. doi: 10.1016/j.coph.2006.01.009. Epub 2006 May 11. Curr Opin Pharmacol. 2006. PMID: 16690355 Review.
-
Multidrug resistance.Cancer Chemother Biol Response Modif. 1999;18:152-77. Cancer Chemother Biol Response Modif. 1999. PMID: 10800482 Review. No abstract available.
-
Role of the breast cancer resistance protein (ABCG2) in drug transport.AAPS J. 2005 May 11;7(1):E118-33. doi: 10.1208/aapsj070112. AAPS J. 2005. PMID: 16146333 Free PMC article.
-
Drug resistance molecules: lessons from oncology.Novartis Found Symp. 2002;243:19-31; discussion 31-7, 180-5. Novartis Found Symp. 2002. PMID: 11990777 Review.
Cited by
-
Applications and challenges of low temperature plasma in pharmaceutical field.J Pharm Anal. 2021 Feb;11(1):28-36. doi: 10.1016/j.jpha.2020.05.001. Epub 2020 May 11. J Pharm Anal. 2021. PMID: 33717609 Free PMC article. Review.
-
iRGD Peptide as a Tumor-Penetrating Enhancer for Tumor-Targeted Drug Delivery.Polymers (Basel). 2020 Aug 24;12(9):1906. doi: 10.3390/polym12091906. Polymers (Basel). 2020. PMID: 32847045 Free PMC article. Review.
-
Metabolically active tumour volume segmentation from dynamic [(18)F]FLT PET studies in non-small cell lung cancer.EJNMMI Res. 2015 Apr 23;5:26. doi: 10.1186/s13550-015-0102-6. eCollection 2015. EJNMMI Res. 2015. PMID: 25932353 Free PMC article.
-
Mucinous and non-mucinous colorectal cancers show differential expression of chemotherapy metabolism and resistance genes.Pharmacogenomics J. 2021 Aug;21(4):510-519. doi: 10.1038/s41397-021-00229-5. Epub 2021 Mar 17. Pharmacogenomics J. 2021. PMID: 33731881
-
Mechanisms of evasive resistance to anti-VEGF therapy in glioblastoma.CNS Oncol. 2013 Jan;2(1):49-65. doi: 10.2217/cns.12.36. CNS Oncol. 2013. PMID: 23750318 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
